Structures by: Wang H. L.
Total: 39
C13H12O4
C13H12O4
Organic letters (2015) 17, 5 1228-1231
a=10.5408(12)Å b=14.0223(15)Å c=15.5670(17)Å
α=90° β=95.216(2)° γ=90°
Copper(II) complex of anthracene-9-imidazoline hydrazone
C18H16Cl2CuN4,C2H6O
Metallomics : integrated biometal science (2015) 7, 7 1124-1136
a=11.3306(3)Å b=14.0417(3)Å c=13.3887(5)Å
α=90.00° β=106.842(4)° γ=90.00°
C18H20O6
C18H20O6
Organic letters (2009) 11, 18 4120-4123
a=9.1170(18)Å b=8.6280(17)Å c=19.717(4)Å
α=90.00° β=95.16(3)° γ=90.00°
C18H21O6
C18H21O6
Organic letters (2009) 11, 18 4120-4123
a=7.4578(12)Å b=15.834(3)Å c=7.0431(12)Å
α=90.00° β=111.745(2)° γ=90.00°
C38H40Dy2N8Ni2O22
C38H40Dy2N8Ni2O22
Dalton Transactions (2019)
a=11.79(3)Å b=13.35(3)Å c=16.23(5)Å
α=90.00° β=110.65(4)° γ=90.00°
C42H54Dy2N8Ni2O22,0.67(O3)
C42H54Dy2N8Ni2O22,0.67(O3)
Dalton Transactions (2019)
a=27.760(6)Å b=13.880(3)Å c=16.570(3)Å
α=90.00° β=106.25(3)° γ=90.00°
C40H48N16Na2Ni2O8
C40H48N16Na2Ni2O8
Dalton Transactions (2019)
a=24.989(6)Å b=11.319(3)Å c=20.032(5)Å
α=90.00° β=123.044(3)° γ=90.00°
C48H32Gd12N16O64
C48H32Gd12N16O64
CrystEngComm (2020) 22, 5 915-923
a=18.4916(16)Å b=18.4916(16)Å c=21.4412(19)Å
α=90° β=90° γ=90°
C20H26Gd2N8O16
C20H26Gd2N8O16
CrystEngComm (2020) 22, 5 915-923
a=8.3885(4)Å b=8.5010(4)Å c=12.0706(6)Å
α=106.955(1)° β=105.901(1)° γ=100.707(1)°
C26H15N6O11Zn2
C26H15N6O11Zn2
CrystEngComm (2017)
a=18.8984(18)Å b=17.7031(18)Å c=14.4754(14)Å
α=90° β=96.602(2)° γ=90°
C26H15N6O11Zn2
C26H15N6O11Zn2
CrystEngComm (2017)
a=31.855(11)Å b=17.268(3)Å c=30.293(14)Å
α=90° β=116.25(3)° γ=90°
C32H80Gd9N16O50
C32H80Gd9N16O50
CrystEngComm (2020) 22, 5 915-923
a=17.3000(2)Å b=17.3000(2)Å c=14.4460(3)Å
α=90° β=90° γ=90°
C30H20Cl6DyN3O4
C30H20Cl6DyN3O4
Dalton transactions (Cambridge, England : 2003) (2018) 47, 44 15929-15940
a=28.994(8)Å b=10.646(3)Å c=23.517(7)Å
α=90.00° β=119.288(5)° γ=90.00°
C32H20Br4ErN5O5
C32H20Br4ErN5O5
Dalton transactions (Cambridge, England : 2003) (2018) 47, 44 15929-15940
a=13.552(4)Å b=16.758(5)Å c=14.397(4)Å
α=90.00° β=97.625(4)° γ=90.00°
4(C30H20Br6DyN3O4),C2H2Cl6,0.5(C2Cl6)
4(C30H20Br6DyN3O4),C2H2Cl6,0.5(C2Cl6)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 44 15929-15940
a=13.3670(4)Å b=13.7483(4)Å c=20.9730(6)Å
α=71.835(3)° β=79.055(3)° γ=86.694(3)°
C32H20Cl4HoN5O5
C32H20Cl4HoN5O5
Dalton transactions (Cambridge, England : 2003) (2018) 47, 44 15929-15940
a=13.2312(18)Å b=16.689(2)Å c=14.3530(19)Å
α=90.00° β=97.769(2)° γ=90.00°
C32H20Cl4N5O5Tb
C32H20Cl4N5O5Tb
Dalton transactions (Cambridge, England : 2003) (2018) 47, 44 15929-15940
a=13.221(3)Å b=16.762(4)Å c=14.398(3)Å
α=90.00° β=97.620(4)° γ=90.00°
C32H20Br4N5O5Tb
C32H20Br4N5O5Tb
Dalton transactions (Cambridge, England : 2003) (2018) 47, 44 15929-15940
a=13.5432(11)Å b=16.8109(13)Å c=14.4543(11)Å
α=90.00° β=97.5140(10)° γ=90.00°
C32H20Br4HoN5O5
C32H20Br4HoN5O5
Dalton transactions (Cambridge, England : 2003) (2018) 47, 44 15929-15940
a=13.5558(2)Å b=16.7642(2)Å c=14.3978(2)Å
α=90.00° β=97.6210(10)° γ=90.00°
C32H20Cl4DyN5O5
C32H20Cl4DyN5O5
Dalton transactions (Cambridge, England : 2003) (2018) 47, 44 15929-15940
a=13.0622(6)Å b=16.6648(8)Å c=14.2828(6)Å
α=90.00° β=97.7270(10)° γ=90.00°
C32H20Br4DyN5O5
C32H20Br4DyN5O5
Dalton transactions (Cambridge, England : 2003) (2018) 47, 44 15929-15940
a=13.583(3)Å b=16.809(4)Å c=14.442(3)Å
α=90.00° β=97.666(4)° γ=90.00°
Hydrocortisone 17-butyrate
C25H36O6
Acta Crystallographica Section E (2014) 70, 12 o1239-o1240
a=9.05738(8)Å b=11.87633(9)Å c=21.13465(15)Å
α=90.00° β=90.00° γ=90.00°
(E)-1-(4-Methoxybenzylidene)semicarbazide
C9H11N3O2
Acta Crystallographica Section E (2007) 63, 6 o2939-o2939
a=13.811(11)Å b=5.443(4)Å c=12.912(10)Å
α=90.00° β=97.933(13)° γ=90.00°
(E)-1-[4-(Dimethylamino)benzylidene]semicarbazide--acetic acid (1/2)
C10H14N4O,2(C2H4O2)
Acta Crystallographica Section E (2007) 63, 6 o2978-o2978
a=7.2931(2)Å b=10.7952(8)Å c=12.2472(7)Å
α=71.422(17)° β=80.020(4)° γ=73.947(4)°
4-(5-Bromo-1,3-dioxoisoindolin-2-yl)benzoic acid N,N-dimethylformamide solvate
C15H8BrNO4,C3H7NO
Acta Crystallographica Section E (2007) 63, 7 o3065-o3065
a=5.9686(9)Å b=8.3214(12)Å c=19.058(3)Å
α=101.231(2)° β=93.417(3)° γ=107.273(2)°
6-Methoxy-2-(2-pyridylmethyliminomethyl)phenol
C14H14N2O2
Acta Crystallographica Section E (2007) 63, 9 o3799-o3799
a=9.0899(2)Å b=5.66260(10)Å c=24.2440(5)Å
α=90.00° β=92.626(2)° γ=90.00°
6-Methoxy-2-[tri(2-pyridyl)methyliminomethyl]phenol
C24H20N4O2
Acta Crystallographica Section E (2007) 63, 10 o4052-o4052
a=8.8601(17)Å b=10.706(2)Å c=11.147(2)Å
α=80.240(8)° β=78.177(8)° γ=87.504(9)°
2-Hydroxy-5-methylbenzene-1,3-dicarbaldehyde
C11H12O3
Acta Crystallographica Section E (2007) 63, 12 o4925-o4925
a=9.1404(3)Å b=16.0798(5)Å c=7.2639(2)Å
α=90.00° β=109.601(2)° γ=90.00°
Bis(diethylenetriamine-κ^3^N,N,N'')nickel(II) bis(1,2-dicyanoethene-1,2-dithiolato-κ^2^S,S')nickel(II)
C8H26N6Ni2,C8N4NiS42
Acta Crystallographica Section E (2008) 64, 10 m1264-m1265
a=9.589(3)Å b=16.910(5)Å c=16.146(4)Å
α=90.00° β=97.491(4)° γ=90.00°
2-(4-Chloroanilino)-3-(2-hydroxyethyl)quinazolin-4(3<i>H</i>)-one
C16H14ClN3O2
Acta Crystallographica Section E (2008) 64, 12 o2325
a=9.0707(18)Å b=11.345(2)Å c=14.143(3)Å
α=90.00° β=96.98(3)° γ=90.00°
2-Anilino-3-(2-hydroxyphenyl)quinazolin-4(3<i>H</i>)-one-- triphenylphosphine oxide (1/1)
C20H15N3O2,C18H15OP
Acta Crystallographica Section E (2010) 66, 10 o2522
a=18.9139(3)Å b=10.3201(2)Å c=18.2145(3)Å
α=90.00° β=117.7710(10)° γ=90.00°
C31H22Cl6DyN3O4,C14H12N2
C31H22Cl6DyN3O4,C14H12N2
Inorganic Chemistry Frontiers (2019) 6, 10 2906
a=17.4552(5)Å b=10.5988(3)Å c=24.3721(6)Å
α=90.00° β=109.2150(10)° γ=90.00°
C31H23Br6DyN3O4,C14H12N2
C31H23Br6DyN3O4,C14H12N2
Inorganic Chemistry Frontiers (2019) 6, 10 2906
a=18.39(4)Å b=11.17(2)Å c=25.90(5)Å
α=90.00° β=108.69(3)° γ=90.00°
C11H10Br2DyN4O11,C14H12N2,C14H13N2
C11H10Br2DyN4O11,C14H12N2,C14H13N2
Inorganic Chemistry Frontiers (2019) 6, 10 2906
a=10.3824(5)Å b=18.8386(11)Å c=21.0988(13)Å
α=90.00° β=99.618(2)° γ=90.00°
C30H18Br6ClDyN3O3,C10H10N
C30H18Br6ClDyN3O3,C10H10N
Inorganic Chemistry Frontiers (2019) 6, 10 2906
a=17.7059(6)Å b=18.3642(4)Å c=13.6199(4)Å
α=90.00° β=111.014(4)° γ=90.00°
C26H19F3N2O2
C26H19F3N2O2
Journal of the American Chemical Society (2014) 136, 33 11590-11593
a=20.238(7)Å b=7.020(2)Å c=16.081(5)Å
α=90° β=104.318(7)° γ=90°
C24H16DyN7O9
C24H16DyN7O9
Dalton transactions (Cambridge, England : 2003) (2018) 47, 44 15929-15940
a=11.1454(3)Å b=17.8782(3)Å c=13.0034(3)Å
α=90.00° β=100.471(2)° γ=90.00°
C32H20Cl4ErN5O5
C32H20Cl4ErN5O5
Dalton transactions (Cambridge, England : 2003) (2018) 47, 44 15929-15940
a=13.2305(3)Å b=16.6540(3)Å c=14.3223(3)Å
α=90.00° β=97.802(2)° γ=90.00°
C45H45Dy3N14O17,CO
C45H45Dy3N14O17,CO
Inorganic Chemistry Frontiers (2018) 5, 12 3155
a=12.6762(9)Å b=13.0303(4)Å c=19.2205(10)Å
α=101.791(4)° β=101.667(5)° γ=111.029(5)°